Table 3.
Variable | Estimate | Standard Error | 95% Confidence Intervals | t Value | P value | |
---|---|---|---|---|---|---|
Intercept | 50.63 | 3.02 | 44.74 | 56.53 | 16.76 | <0.01 |
Week 1 | −5.87 | 2.51 | −10.76 | −0.98 | −2.34 | 0.02 |
Week 2 | −7.43 | 2.51 | −12.32 | −2.54 | −2.96 | <0.01 |
Week 3 | −1.08 | 2.51 | −5.97 | 3.81 | −0.43 | 0.67 |
active tDCS | 4.42 | 4.27 | −3.92 | 12.76 | 1.03 | 0.30 |
Week 1: active tDCS | −3.25 | 3.55 | −10.17 | 3.67 | −0.92 | 0.36 |
Week 2: active tDCS | −9.63 | 3.55 | −16.55 | −2.72 | −2.71 | <0.01 |
Week 3: active tDCS | −22.98 | 3.55 | −29.90 | −16.07 | −6.48 | <0.0001 |
Note. The baseline is used as the reference level for the time factor, and the sham tDCS group is used as the reference level for the intervention factor. “Week 1: active tDCS” denotes the interaction between the time factor and the treatment.